Latest goodwill for ATTBF: $3.2M.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
Abattis Bioceuticals (ATTBF) currently reports a goodwill of $3.2M as of September 2019. In the prior-year period, the figure was $0. Use the charts on this page to explore Abattis Bioceuticals's goodwill history and peer comparisons.
Abattis Bioceuticals's goodwill changed from $0 to $3.2M (period ending September 2019). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.
Abattis Bioceuticals reported $3.2M in goodwill as of September 2019. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.
Start with the current goodwill of $3.2M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Abattis Bioceuticals, and consider following ATTBF for alerts when major investors trade the stock.
Abattis Bioceuticals is classified in the Healthcare sector. On goodwill, it currently shows $3.2M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing ATTBF with unrelated industries.